Healthcare

Following the release of its 2025 annual results, Protara Therapeutics has shifted investor attention squarely to its clinical pipeline. The...

Investors in Spero Therapeutics are closely monitoring the coming weeks, which could prove pivotal for the company’s fight against multidrug-resistant...

For income-focused investors, the announcement of a confirmed dividend payment from Universal Health Realty Income Trust provides a measure of...

A notable shift is occurring within the shareholder base of medical technology firm Fractyl Health. Specialized investment firms are accumulating...

Amazon is accelerating its artificial intelligence strategy with unprecedented financial commitments, fundamentally reshaping its growth narrative. The tech giant is...

Ahead of the quarterly dividend distribution scheduled for Tuesday, significant repositioning activity is being observed among major investors in UnitedHealth...

Pfizer's ambitious portfolio transformation is beginning to yield tangible results. A significant milestone was achieved with the recent regulatory approval...

Major investment firms are building significant positions in Danaher Corporation, signaling confidence in the life sciences and diagnostics specialist despite...

As March 2026 unfolds, Innoviva continues to solidify its standing within the specialized healthcare market. Investor attention is pivoting toward...

Sangamo Therapeutics is advancing decisively with its investigational gene therapy, ST-920, for Fabry disease. The company has submitted critical data...